Skip to main content
. 2010 Mar 25;1(6):420–434. doi: 10.1021/cn100007x

Table 1. Marketed Drug Set by Name.

Central Nervous System Drugs
acamprosate fluvoxamine propoxyphene
alprazolam gabapentin quazepam
amfebutamone galantamine quetiapine
amisulpride haloperidol ramelteon
amphetamine hydrocodone rasagiline
aniracetam indeloxazine reboxetine
apomorphine lamotrigine remifentanil
aprepitant levetiracetam riluzole
aripiprazole levomethadyl rimonabant
atomoxetine lofexidine risperidone
bromazepam lorazepam rivastigmine
bromocriptine meprobamate ropinirole
brotizolam methylphenidate ropivacaine
budipine metoclopramide selegiline
buprenorphine midazolam sertindole
buspirone milnacipran sertraline
cabergoline minaprine sinequan
caffeine mirtazapine sulpiride
carbamazepine moclobemide tacrine
carisoprodol modafinil talipexole
chlorpromazine morphine terguride
citalopram nalmefene thiopental
clomipramine naltrexone tiagabine
clonazepam nemonapride tianeptine
clozapine nicergoline topiramate
cyclobenzaprine nicotrol tramadol
dexmethylphenidate nimodipine trazodone
dextropropoxyphene nortriptyline tropisetron
diazepam olanzapine valproic acid
donepezil oxcarbazepine varenicline
dronabinol oxycodone venlafaxine
duloxetine paliperidone verapamil
eletriptan paroxetine vigabatrin
escitalopram pergolide vinpocetine
eszopiclone perospirone zaleplon
ethosuximide phenytoin ziprasidone
felbamate piracetam zolpidem
fentanyl pramipexole zonisamide
flumazenil pregabalin zotepine
fluoxetine propofol